xromi
nova laboratories ireland limited - hýdroxýkarbamíð - blóðleysi, blóðkorn - Æxlishemjandi lyf - fyrirbyggja vaso-tum fylgikvillar sker klefi sjúkdóminn í sjúklingar yfir 2 ára aldri.
jayempi
nova laboratories ireland limited - azathioprine - graft rejection - Ónæmisbælandi lyf - jayempi is indicated in combination with other immunosuppressive agents for the prophylaxis of transplant rejection in patients receiving allogenic kidney, liver, heart, lung or pancreas transplants. azathioprine is indicated in immunosuppressive regimens as an adjunct to immunosuppressive agents that form the mainstay of treatment (basis immunosuppression). jayempi is used as an immunosuppressant antimetabolite either alone or, more commonly, in combination with other agents (usually corticosteroids) and/ or procedures which influence the immune response. jayempi is indicated in patients who are intolerant to glucocorticosteroids or if the therapeutic response is inadequate despite treatment with high doses of glucocorticosteroids, in the following diseases:severe active rheumatoid arthritis (chronic polyarthritis) that cannot be kept under control by less toxic agents (disease-modifying anti-rheumatic -medicinal products – dmards)auto-immune hepatitis systemic lupus erythematosusdermatomyositispolyarteritis nodosapemphigus vulgaris and bullous pemphigoidbehçet’s diseaserefractory auto-immune haemolytic anaemia, caused by warm igg antibodieschronic refractory idiopathic thrombocytopenic purpurajayempi is used for the treatment of moderately severe to severe forms of chronic inflammatory bowel disease (ibd) (crohn’s disease or ulcerative colitis) in patients in whom glucocorticosteroid therapy is necessary, but where glucocorticosteroids are not tolerated, or in whom the disease is untreatable with other common means of first choice. it is also indicated in adult patients in relapsing multiple sclerosis, if an immunomodulatory therapy is indicated but beta interferon therapy is not possible, or a stable course has been achieved with previous treatment with azathioprine. 3jayempi is indicated for the treatment of generalised myasthenia gravis. depending on the severity of the disease, jayempi should be given in combination with glucocorticosteroids because of slow onset of action at the beginning of treatment and the glucocorticosteroid dose should be gradually reduced after several months of treatment.
combisyn stungulyf, dreifa 14,0/3,5 % w/v
norbrook laboratories (ireland) limited - amoxicillinum tríhýdrat; acidum clavulanicum kalíum - stungulyf, dreifa - 14,0/3,5 % w/v
combisyn tafla 250 mg
norbrook laboratories (ireland) limited - amoxicillinum tríhýdrat; acidum clavulanicum kalíum - tafla - 250 mg
combisyn tafla 50 mg
norbrook laboratories (ireland) limited - amoxicillinum tríhýdrat; acidum clavulanicum kalíum - tafla - 50 mg
flunixin (flunixin solutions for injection) stungulyf, lausn 50 mg/ml
norbrook laboratories (ireland) limited - flunixinum meglúmínsalt - stungulyf, lausn - 50 mg/ml
noromectin (noromectin 1.87% oral paste for horses) pasta til inntöku 1,87 %
norbrook laboratories (ireland) limited - ivermectinum inn - pasta til inntöku - 1,87 %
viracept
roche registration ltd. - nelfínavír - hiv sýkingar - veirueyðandi lyf til almennrar notkunar - viracept er ætlað í antiretroviral samsetning meðferð manna-ónæmisgalla-veira (hiv-1)-sýkt fullorðnir, unglingum og börn þriggja ára og eldri. Í próteasa-hemil (pi)-upplifað sjúklingar, val nelfínavír ætti að vera byggt á einstökum veiru mótstöðu próf og meðferð sögu.
qaialdo
nova laboratories ireland limited - spironolactone - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 5.
xyrem
ucb pharma ltd - natríumoxýbat - cataplexy; narcolepsy - Önnur lyf í taugakerfinu - meðferð við narkólsi með kataplexi hjá fullorðnum sjúklingum.